Article
Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.
Vaccine - 18 Sept 2018
Cowley Daniel, Nirwati Hera, Donato Celeste M, Bogdanovic-Sakran Nada, Boniface Karen, Kirkwood Carl D, Bines Julie E
Abstract excerpt
BACKGROUND: The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth. The aim of the current study was to characterise the rotavirus strains causing gastroenteritis during the Indonesian Phase IIb efficacy trial. METHODS: A randomized, double-blind placebo-controlled trial involving 1649 participants was conducted from January 2013 to July 2016 in Central...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
